comparemela.com
Home
Live Updates
PSMA-Directed Targeted Alpha Therapy Shows Activity in Heavi
PSMA-Directed Targeted Alpha Therapy Shows Activity in Heavi
PSMA-Directed Targeted Alpha Therapy Shows Activity in Heavily Pretreated Metastatic CRPC
FPI-2265 showed promising activity in patients with metastatic castration-resistant prostate cancer which was similar to prior safety and efficacy data reported.
Related Keywords
Houston ,
Texas ,
United States ,
Ebrahim Delpassand ,
Nuclear Oncology Center ,
Enrollment Criteria ,
Excel Diagnostics ,
Aacr Annual Meeting ,
Crpc ,
Prostate Cancer ,
Fpi 2265 ,
Phase 2 Tatcist Trial Nct05219500 ,